In the pharmaceutical industry today, POZEN is uniquely positioned leveraging the benefits of our efficient in-source business model and our strategic partnerships.

This model has allowed POZEN to commit nearly all of our resources to developing new products while avoiding the high costs associated with basic research, manufacturing, and marketing.

By virtue of the initial upfront payments, milestone payments, and ongoing royalties from partnerships, POZEN has been exclusively self-funding since the Initial Public Offering (IPO) in 2000.

Investors

POZEN Inc., headquartered in Chapel Hill, NC, is a progressive pharmaceutical company committed to addressing unmet medical needs and providing affordable medicines to patients and physicians.

Since its founding in 1996, POZEN has successfully created novel pharmacologic agents primarily for pain and pain-related conditions by combining existing drug therapies that result in superior patient outcomes. POZEN’s unique in-source business model has been proven with its success in gaining U.S. FDA approval of two self-invented products in two years—something almost no other small pharmaceutical company has achieved.

POZEN’s lead product PA32540 is a component of POZEN’s pipeline of cost-effective, integrated therapies that are designed to enable the full power of aspirin by reducing its GI damage—with the potential to benefit the millions of Americans who use aspirin for cardiovascular disease prevention. POZEN is seeking to secure a strategic license agreement with one or more partners by the end of 2012 to maximize the sales potential of PA32540.

Conferences/Presentations

Piper Jaffray Healthcare Conference December 3, 2013

Piper Jaffray Healthcare Conference November 27, 2012

Jefferies 2012 Global Healthcare Conference June 5, 2012

11th Annual Needham Healthcare Conference April 3, 2012

24th Annual ROTH Conference March 14, 2012

Piper Jaffray Healthcare Conference November 30, 2011

Lazard Capital Markets Healthcare Conference November 15, 2011

Brean Murray Carret & Co LLC Life Sciences Summit November 14, 2011

Stifel, Nicolaus & Company Inc. Healthcare Conference September 7, 2011

Wells Fargo 2011 Global Life Sciences Conference June 22, 2011

POZEN Inc. Rings The NASDAQ Stock Market Closing Bell December 8, 2009

Recent News